Rachel Greenberg, MD, MB, MHS

Duke Clinical Research Institute

Disclosure(s): Provepharm Inc: Advisor/Consultant; Tellus Therapeutics: Advisor/Consultant

Poster(s):

• 565 - Pilot Study of Prolonged Post-Discontinuation Antibiotic Exposure (PDAE) to Ampicillin Among Low Birthweight Preterm Infants
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET